Zhiqing Tang

Dr. Zhiqing Tang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
KHKaiyue Han
Kaiyue Han
JLJiajie Liu
Jiajie Liu
ZTZhiqing Tang
Zhiqing Tang
WSWenlong Su
Wenlong Su
YLYing Liu
Ying Liu
HZHao Zhang
Hao Zhang
Background: Post-stroke cognitive impairment (PSCI) is a significant health concern. Transcranial magnetic stimulation (TMS) is considered a promising rehabilitation therapy for improving cognition, and the effects of excitatory TMS on PSCI have received much attention in recent years. However, the effects of different cerebral hemispheres on excitatory TMS treatment of cognitive impairment have not been studied. This review aimed to study the effects of excitatory TMS over the dorsolateral prefrontal cortex (DLPFC) of different cerebral hemispheres on the cognitive function of patients with PSCI.Methods: Literature published in PubMed, Web of Science, Embase, Cochrane Library, Scopus, and Wiley from inception to September 30, 2022, were searched. Two researchers independently performed literature screening, data extraction, and quality assessment. Furthermore, we conducted a meta-analysis using RevMan software (version 5.4) and rated the strength of evidence using GRADEpro.Results: A total of 19 studies were included in this meta-analysis. The results showed that excitatory TMS over the left hemisphere DLPFC was significantly better in improving global cognition (SMD = 2.26, 95% CI 1.67–2.86, P < 0.00001; vs. SMD = 2.53, 95% CI 1.86–3.20, P < 0.00001), memory (SMD = 1.29, 95% CI 0.72–1.87, P < 0.0001), attention (SMD = 2.32, 95% CI 1.64–3.01, P < 0.00001), executive (SMD = 0.64, 95% CI 0.21–1.07, P = 0.004), P300 latency (SMD = 2.69, 95% CI 2.13–3.25, P < 0.00001), and depression (SMD = 0.95, 95% CI 0.26–1.63, P = 0.007) than that of the control group, but the effect on improving activities of daily living (ADL) was unclear (P = 0.03 vs. P = 0.17). Subgroup analysis further showed that excitatory TMS over the right hemisphere DLPFC was effective in improving the global cognition of PSCI patients (P < 0.00001), but the stimulation effect over the ipsilateral hemisphere DLPFC was unclear (P = 0.11 vs. P = 0.003). Additionally, excitatory TMS over the ipsilateral hemisphere DLPFC showed no statistical difference in improving ADL between the two groups (P = 0.25).Conclusions: Compared to other hemispheric sides, excitatory TMS over the left hemisphere DLPFC was a more effective stimulation area, which can significantly improved the global cognitive function, memory, attention, executive, P300 latency, and depression in patients with PSCI. There was no apparent therapeutic effect on improving activities of daily living (ADL). In the future, more randomized controlled trials with large-sample, high quality, and follow-up are necessary to explore a usable protocol further.Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier: CRD42022369096.

1 September 2024 in Stroke
Verified
Journal Article
Open access
ZTZhiqing Tang
Zhiqing Tang
JHJianting Huang
Jianting Huang
YZYing Zhou
Ying Zhou
JRJianxun Ren
Jianxun Ren
XDXinyu Duan
Xinyu Duan
HLHesheng Liu
Hesheng Liu
BACKGROUND: Upper extremity (UE) motor function impairment is a major poststroke complication whose recovery remains one of the most challenging tasks in neurological rehabilitation. This study examined the efficacy and safety of the personalized neuroimaging–guided high-dose theta-burst stimulation (TBS) for poststroke UE motor function recovery. METHODS: Patients after stroke with UE motor impairment from a China rehabilitation center were randomly assigned to receive high-dose intermittent TBS (iTBS) to ipsilesional UE sensorimotor network, continuous TBS (cTBS) to contralesional UE sensorimotor network, or sham stimulation, along with conventional therapy for 3 weeks. The primary outcome was the score changes on the Fugl-Meyer assessment-UE from baseline to 1 and 3 weeks. The secondary outcomes included the response rate on Fugl-Meyer assessment-UE scores posttreatment (≥9-point improvement) and score changes in multidimensional scales measuring UE, lower extremity, and activities and participation. RESULTS: From June 2021 to June 2022, 45 participants were randomized and 43 were analyzed. The iTBS and continuous TBS groups showed significantly greater improvement in Fugl-Meyer assessment-UE (mean improvement, iTBS: 10.73 points; continuous TBS: 10.79 points) than the sham group (2.43 points) and exhibited significantly greater response rates on Fugl-Meyer assessment-UE (iTBS, 60.0%; continuous TBS, 64.3%) than the sham group (0.0%). The active groups consistently exhibited superior improvement on the other 2 UE assessments at week 3. However, only the iTBS group showed greater efficacy on 1 lower extremity assessment than the sham group at week 3. Both active groups showed significant improvements in activities and participation assessments. CONCLUSIONS: The study provides evidence for the efficacy and safety of high-dose TBS in facilitating poststroke UE rehabilitation. REGISTRATION: URL: www.chictr.org.cn ; Unique identifier: ChiCTR2100047340.

30 May 2026 in Brain Research Bulletin
Verified
Journal Article
Open access
ZTZhiqing Tang
Zhiqing Tang
LDLinghui Dong
Linghui Dong
HLHui Li
Hui Li
WRWeijing Ren
Weijing Ren
JLJunzi Long
Junzi Long
QCQianqian Chi
Qianqian Chi
Post-stroke upper limb motor dysfunction is associated with complex alterations in brain function, but the frequency-specific characteristics of spontaneous local neural activity remain incompletely understood. This study investigated multi-metric resting-state functional magnetic resonance imaging (rs-fMRI) alterations in stroke patients with upper limb motor dysfunction and explored their discriminative value using machine-learning classifiers. A total of 70 stroke patients and 45 healthy controls (HCs) underwent rs-fMRI. Fractional amplitude of low-frequency fluctuations (fALFF), percent amplitude of fluctuation (PerAF), and wavelet transform-based amplitude of low-frequency fluctuations (Wavelet-ALFF) were calculated across the conventional band (0.01-0.08Hz), Slow-4 band (0.027-0.073Hz), and Slow-5 band (0.01-0.027Hz). Voxel-wise group comparisons were performed with age, sex, and mean framewise displacement as covariates. Lesion mapping, lesion-volume analysis, and a subcortical-lesion subgroup sensitivity analysis were conducted to assess lesion-related effects. Regional features showing significant group differences were used to construct support vector machine (SVM), Random Forest, and XGBoost classifiers, and model performance was evaluated on an independent testing set. Compared with HCs, stroke patients showed widespread frequency-specific alterations in cerebellar, visual, cingulo-motor, temporal, insular, subcortical, and frontal regions. Core abnormalities in cerebellar, visual, cingulate, supplementary motor, and frontal regions were largely retained in the subcortical-lesion subgroup. Lesion volume was negatively correlated with Fugl-Meyer Assessment for Upper Extremity scores. Several nominal associations were observed between Slow-5 fALFF features in visual regions and motor impairment severity, but none survived false discovery rate correction. Among all testing-set models, the SVM classifier using combined multi-metric Slow-4 and Slow-5 features achieved the highest numerical performance, with an AUC of 0.956, accuracy of 0.912, sensitivity of 0.905, and specificity of 0.923. However, DeLong tests showed no statistically significant superiority of sub-frequency features over conventional-band features. Stroke patients with upper limb motor dysfunction exhibit distributed, frequency-specific alterations in spontaneous local brain activity. Multi-metric rs-fMRI features, particularly combined sub-frequency features, may have exploratory discriminative value, but external validation is needed before they can be considered robust imaging biomarkers.